3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2/3
1
Status
Completed
19
Terminated
7
Recruiting
6
Unknown
3
Enrolling by invitation
2
Withdrawn
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Classical hematology
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Hemostatic Disorders
1
Interventions
Cisplatin
504
Cyclophosphamide
353
Radiotherapy
349
Carboplatin
347
Capecitabine
328
Oxaliplatin
319
Paclitaxel
316
Gemcitabine
315
Docetaxel
308
Fluorouracil
281
apatinib
240
Drug Therapy
239
Bevacizumab
224
camrelizumab
212
Etoposide
199
Irinotecan
176
Doxorubicin
174
Dexamethasone
159
Leucovorin
158
sintilimab
140
Pemetrexed
136
Cytarabine
136
pembrolizumab
135
anlotinib
135
toripalimab
124
S 1 (combination)
119
Neoadjuvant Therapy
119
Vincristine
118
Rituximab
114
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Enoxaparin
×
Clear all
NCT04999176
2021-08-10
VALERIA
Science Valley Research Institute
Phase 3
Unknown
440 enrolled
NCT04462003
2020-07-08
DVT
Beni-Suef University
Phase 3
Unknown
100 enrolled
NCT03570281
2018-06-26
ENCHASE
Samsung Medical Center
Phase 2/3
Unknown
40 enrolled